Turbidimetry is about how cloudy a solution is by looking at how much light can pass through it. In a suspension with particles, light is scattered out of the straight path, so less of the incident beam reaches the detector. A turbidimeter measures the transmitted light, and the amount that passes through decreases as turbidity increases. That is why describing turbidimetry as a measurement of the amount of light to pass through a turbid solution is the best fit. By comparison, measuring color intensity relates to colorimetry, measuring light scattered by a sample relates to nephelometry, and measuring mass-to-charge ratio is a mass spectrometry concept.

Nephrotic syndrome causes heavy protein loss in the urine, which lowers circulating proteins—especially albumin—and leads to hypoalbuminemia and a decrease in total serum protein. In response, the liver increases production of lipoproteins to restore oncotic balance and transport lipids, resulting in hyperlipidemia. So the expected pattern is higher cholesterol, higher triglycerides, and lower total protein. This matches the choice with increased TCHOL, decreased TP, and increased TRIG. Other patterns would not fit the underlying changes: lipid levels wouldn’t rise if protein loss weren’t driving hepatic lipoprotein production, and total protein wouldn’t drop if there wasn’t substantial protein loss.

Icterus can interfere with some lab tests because bilirubin changes the color and optical properties of a sample, which can affect measurements that rely on light absorbance or color signals. Among the options, the one that is both a cardiac biomarker and subject to this kind of interference on some platforms is high-sensitivity troponin I. Troponin I is the standout indicator of heart muscle injury and is used to detect myocardial infarction. The other substances—estradiol, parathyroid hormone, and testosterone—are hormones or related peptides and are not cardiac injury markers, so they don’t fit the cardiac biomarker part of the prompt.

When a blood sample is drawn from or near an IV fluid line, the result can be a mix of the patient’s blood with the IV solution. If the IV contains dextrose, glucose in the sample can be falsely very high; the same fluid dilutes plasma components, so total protein drops and electrolytes like sodium and potassium can appear low. Here, glucose is markedly elevated while total protein, sodium, and potassium are all decreased, which fits the picture of dilution from IV fluids plus glucose infusate rather than a true patient profile. The correct action is to reject the sample and recollect from a venipuncture away from any IV line, after flushing or stopping the IV as appropriate. (Hemolysis would usually alter potassium and other values in a different pattern and wouldn’t explain such a massive spike in glucose with concurrent dilution across other analytes.)